New drug/company AUXL on my radar meets early JAZZ profile objectives; pre runnup
1) Approved drug already on the market
2) Ongoing clinical trial to prove efficacy for other conditions
3) Ongoing NDA with FDA
As most here know, Jazz's earnings SOARED as a by product of our lead drugs off label use in the treatment of fibromyalgia -an almost pandemic condition throughout the USA and the world.
If you agree with this thesis, check out AUXL. Their lead drug XIAFLEX has been approved by the FDA for Dupuytrens Contracture - a condition that effects the ligaments in the hand. Current clinical trials are proving that the drug not only works well in this arena, but has broadened application in the field of "Frozen Shoulder", An erectile dysfunction known as Peyronies that affects millions of men over 40 as well as ...get this: CELLULITE DIMPLES!!
THIS PRODUCTS MARKET IS ALMOST LIMITLESS. In fact, I will admit that while I've loved the JAZZ ride, AUXL looks better from a product perspective than JAZZ ever did.